Background: We hypothesized that metabolic profiles would differ in critically ill patients with malnutrition relative to those without. Materials and Methods: We performed a prospective cohort study on 85 adult patients with systemic inflammatory response syndrome or sepsis admitted to a 20-bed medical intensive care unit (ICU) in Boston. We generated metabolomic profiles using gas and liquid chromatography and mass spectroscopy. We followed this by logistic regression and partial least squares discriminant analysis to identify individual metabolites that were significant. We then interrogated the entire metabolomics profile using metabolite set enrichment analysis and network model construction of chemical-protein target interactions to identify groups of metabolites and pathways that were differentiates in patients with and without malnutrition. Results: Of the cohort, 38% were malnourished at admission to the ICU. Metabolomic profiles differed in critically ill patients with malnutrition relative to those without. Ten metabolites were significantly associated with malnutrition (P < .05). A parsimonious model of 5 metabolites effectively differentiated patients with malnutrition (AUC = 0.76), including pyroglutamine and hypoxanthine. Using pathway enrichment analysis, we identified a critical role of glutathione and purine metabolism in predicting nutrition. Nutrition status was associated with 28-day mortality, even after adjustment for known phenotypic variables associated with ICU mortality. Importantly, 7 metabolites associated with nutrition status were also associated with 28-day mortality. Conclusion: Malnutrition is associated with differential metabolic profiles early in critical illness. Common to all of our metabolome analyses, glutathione and purine metabolism, which play principal roles in cellular redox regulation and accelerated tissue adenosine triphosphate degradation, respectively, were significantly altered with malnutrition.
WestergrenALindholmCAxelssonCUlanderK. Prevalence of eating difficulties and malnutrition among persons within hospital care and special accommodations. J Nutr Health Aging. 2008;12(1):39-43.
2.
PlanasMAudivertSPerez-PortabellaC. Nutritional status among adult patients admitted to a university-affiliated hospital in Spain at the time of genoma. Clin Nutr. 2004;23(5):1016-1024.
3.
KruizengaHMWierdsmaNJvan BokhorstMA. Screening of nutritional status in The Netherlands. Clin Nutr. 2003;22(2):147-152.
4.
PirlichMSchutzTNormanK. The German hospital malnutrition study. Clin Nutr. 2006;25(4):563-572.
5.
McWhirterJPPenningtonCR. Incidence and recognition of malnutrition in hospital. BMJ. 1994;308(6934):945-948.
6.
KondrupJJohansenNPlumLM. Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. Clin Nutr. 2002;21(6):461-468.
7.
RasmussenHHKondrupJStaunMLadefogedKKristensenHWenglerA. Prevalence of patients at nutritional risk in Danish hospitals. Clin Nutr. 2004;23(5):1009-1015.
8.
GinerMLavianoAMeguidMMGleasonJR. In 1995 a correlation between malnutrition and poor outcome in critically ill patients still exists. Nutrition. 1996;12(1):23-29.
9.
NormanKPichardCLochsHPirlichM. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27(1):5-15.
10.
Cartin-CebaRAfessaBGajicO. Low baseline serum creatinine concentration predicts mortality in critically ill patients independent of body mass index. Crit Care Med. 2007;35(10):2420-2423.
11.
DvirDCohenJSingerP. Computerized energy balance and complications in critically ill patients: an observational study. Clin Nutr. 2006;25(1):37-44.
12.
TremblayABandiV. Impact of body mass index on outcomes following critical care. Chest. 2003;123(4):1202-1207.
13.
RobinsonMKMogensenKMCaseyJD. The relationship among obesity, nutritional status, and mortality in the critically ill. Crit Care Med. 2015;43(1):87-100.
14.
MogensenKMRobinsonMKCaseyJD. Nutritional status and mortality in the critically ill. Crit Care Med. 2015;43(12):2605-2615.
15.
IhmelsJLevyRBarkaiN. Principles of transcriptional control in the metabolic network ofSaccharomyces cerevisiae. Nat Biotechnol. 2004;22(1):86-92.
16.
TakigawaIMamitsukaH. Probabilistic path ranking based on adjacent pairwise coexpression for metabolic transcripts analysis. Bioinformatics. 2008;24(2):250-257.
17.
RavaszESomeraALMongruDAOltvaiZNBarabasiAL. Hierarchical organization of modularity in metabolic networks. Science. 2002;297(5586):1551-1555.
18.
KiehntopfMNinNBauerM. Metabolism, metabolome, and metabolomics in intensive care: is it time to move beyond monitoring of glucose and lactate?Am J Respir Crit Care Med. 2013;187(9):906-907.
19.
Izquierdo-GarciaJLNinNRuiz-CabelloJ. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med. 2011;37(12):2023-2032.
20.
MickiewiczBVogelHJWongHRWinstonBW. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality. Am J Respir Crit Care Med. 2013;187(9):967-976.
21.
RogersAJMcGeachieMBaronRM. Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One. 2014;9(1):e87538.
22.
StringerKASerkovaNJKarnovskyAGuireKPaineRIIIStandifordTJ. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma (1)H-nuclear magnetic resonance quantitative metabolomics and computational analysis. Am J Physiol Lung Cell Mol Physiol. 2011;300(1):L4-L11.
23.
DolinayTKimYSHowrylakJ. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med. 2012;185(11):1225-1234.
24.
DolinayTKimYSHowrylakJ. Inflammasome-regulated cytokines are critical mediators of acute lung injury. Am J Respir Crit Care Med. 2012;185(11):1225-1234.
25.
MurphySNChuehHC. A security architecture for query tools used to access large biomedical databases. Proc AMIA Symp. 2002:552-556.
26.
SwailsWSSamourPQBabineauTJBistrianBR. A proposed revision of current ICD-9-CM malnutrition code definitions. J Am Diet Assoc. 1996;96(4):370-373.
27.
BlackburnGLBistrianBRMainiBSSchlammHTSmithMF. Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr. 1977;1(1):11-22.
28.
SimopoulosAP. Obesity and body weight standards. Annu Rev Public Health. 1986;7:481-492.
29.
SohnMWArnoldNMaynardCHynesDM. Accuracy and completeness of mortality data in the Department of Veterans Affairs. Popul Health Metr. 2006;4:2.
30.
LevyMMFinkMPMarshallJC. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250-1256.
31.
BernardGRArtigasABrighamKL. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149(3, pt 1):818-824.
32.
KnausWADraperEAWagnerDPZimmermanJE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
33.
LawtonKABergerAMitchellM. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;9(4):383-397.
34.
SreekumarAPoissonLMRajendiranTM. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457(7231):910-914.
35.
DeLongERDeLongDMClarke-PearsonDL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
36.
PencinaMJD’AgostinoRBSr.D’AgostinoRBJrVasanRS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157-172, discussion 207-212.
37.
XiaJPsychogiosNYoungNWishartDS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37(Web Server issue):W652-W660.
38.
XiaJSinelnikovIVHanBWishartDS. MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251-W257.
39.
MatthewBWilliamR. Partial least squares for discrimination. J Chemometrics. 2003;17(3):166-173.
40.
XiaJWishartDS. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 2010;38(Web Server issue):W71-W77.
41.
WishartDSJewisonTGuoAC. HMDB 3.0—the Human Metabolome Database in 2013. Nucleic Acids Res. 2013;41(Database issue):D801-D807.
42.
HolmS. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
43.
GoemanJJvan de GeerSAde KortFvan HouwelingenHC. A global test for groups of genes: testing association with a clinical outcome. Bioinformatics. 2004;20(1):93-99.
44.
HoutkooperRHArgmannCHoutenSM. The metabolic footprint of aging in mice. Sci Rep. 2011;1:134.
45.
KuhnMSzklarczykDPletscher-FrankildS. STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res. 2014;42(Database issue):D401-D407.
46.
LangleyRJTsalikELvan VelkinburghJC. An integrated clinico-metabolomic model improves prediction of death in sepsis. Sci Transl Med. 2013;5(195):195ra195.
47.
LangleyRJTipperJLBruseS. Integrative “omic” analysis of experimental bacteremia identifies a metabolic signature that distinguishes human sepsis from systemic inflammatory response syndromes. Am J Respir Crit Care Med. 2014;190(4):445-455.
48.
GoodeHFCowleyHCWalkerBEHowdlePDWebsterNR. Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med. 1995;23(4):646-651.
49.
GalleyHFDaviesMJWebsterNR. Xanthine oxidase activity and free radical generation in patients with sepsis syndrome. Crit Care Med. 1996;24(10):1649-1653.
50.
CowleyHCBaconPJGoodeHFWebsterNRJonesJGMenonDK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med. 1996;24(7):1179-1183.
51.
ChuangCCShieshSCChiCH. Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis. Crit Care. 2006;10(1):R36.
52.
ArnalichFGarcia-PalomeroELopezJ. Predictive value of nuclear factor kappaB activity and plasma cytokine levels in patients with sepsis. Infect Immun. 2000;68(4):1942-1945.
53.
PatersonRLGalleyHFDhillonJKWebsterNR. Increased nuclear factor kappa B activation in critically ill patients who die. Crit Care Med. 2000;28(4):1047-1051.
54.
JainSKMicinskiD. Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem Biophys Res Commun. 2013;437(1):7-11.
55.
BioloGAntonioneRDe CiccoM. Glutathione metabolism in sepsis. Crit Care Med. 2007;35(9)(suppl):S591-S595.
PachtERTimermanAPLykensMGMerolaAJ. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest. 1991;100(5):1397-1403.
58.
IyerSSJonesDPBrighamKLRojasM. Oxidation of plasma cysteine/cystine redox state in endotoxin-induced lung injury. Am J Respir Cell Mol Biol. 2009;40(1):90-98.
59.
GrumCMSimonRHDantzkerDRFoxIH. Evidence for adenosine triphosphate degradation in critically-ill patients. Chest. 1985;88(5):763-767.
60.
ChristensenEFJacobsenJAnker-MollerESchultzPSpangsbergN. Increased urinary loss of uric acid in adults with acute respiratory failure requiring mechanical ventilation. Chest. 1992;102(2):556-559.
61.
WoolliscroftJOFoxIH. Increased body fluid purine levels during hypotensive events: evidence for ATP degradation. Am J Med. 1986;81(3):472-478.
62.
OzawaKAoyamaHYasudaK. Metabolic abnormalities associated with postoperative organ failure: a redox theory. Arch Surg. 1983;118(11):1245-1251.
63.
SahebjaniH. Changes in urinary uric acid excretion in obstructive sleep apnea before and after therapy with nasal continuous positive airway pressure. Chest. 1998;113(6):1604-1608.
64.
SaitoHNishimuraMShibuyaE. Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine. Chest. 2002;122(5):1686-1694.
65.
HarknessRA. Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion. J Chromatogr. 1988;429:255-278.
66.
JabsCMNeglenPEklofB. Breakdown of adenine nucleotides, formation of oxygen free radicals, and early markers of cellular injury in endotoxic shock. Eur J Surg. 1995;161(3):147-155.
67.
WoolliscroftJOPrasadJKThomsonPTillGOFoxIH. Metabolic alterations in burn patients: detection of adenosine triphosphate degradation products and lipid peroxides. Burns. 1990;16(2):92-96.
SuloGVollsetSENygardO. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol. 2013;168(2):1435-1440.
70.
Adams WilsonJRMorandiAGirardTD. The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness. Crit Care Med. 2012;40(3):835-841.
71.
OzkanYSukurogluMKTulmacMKisaUSimsekB. Relation of kynurenine/tryptophan with immune and inflammatory markers in coronary artery disease. Clin Lab. 2014;60(3):391-396.
72.
SoltowQAStrobelFHMansfieldKGWachtmanLParkYJonesDP. High-performance metabolic profiling with dual chromatography–Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome. Metabolomics. 2013;9(1)(suppl):S132-S143.
73.
XiaJWishartDS. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc. 2011;6(6):743-760.
74.
BijlsmaSBobeldijkIVerheijER. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal Chem. 2006;78(2):567-574.
75.
HoPMPetersonPNMasoudiFA. Evaluating the evidence: is there a rigid hierarchy?Circulation. 2008;118(16):1675-1684.
76.
SchneiderSMVeyresPPivotX. Malnutrition is an independent factor associated with nosocomial infections. Br J Nutr. 2004;92(1):105-111.
77.
MogensenKMRobinsonMKCaseyJD. Nutritional status and mortality in the critically ill. Crit Care Med. 2015;43(12):2605-2615.
78.
YakesFMVan HoutenB. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci U S A. 1997;94(2):514-519.
79.
GrishkoVSolomonMWilsonGLLeDouxSPGillespieMN. Oxygen radical-induced mitochondrial DNA damage and repair in pulmonary vascular endothelial cell phenotypes. Am J Physiol Lung Cell Mol Physiol. 2001;280(6):L1300-L1308.
80.
ZhangQRaoofMChenY. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104-107.
81.
NakahiraKKyungSYRogersAJ. Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med. 2013;10(12):e1001577.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
